|
市場調査レポート
商品コード
1385047
ソフトジェルカプセルの世界市場規模、シェア、産業動向分析レポート:タイプ別、用途別、流通チャネル別、地域別展望と予測、2023年~2030年Global Softgel Capsules Market Size, Share & Industry Trends Analysis Report By Type (Gelatin, and Non-gelatin), By Application, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
ソフトジェルカプセルの世界市場規模、シェア、産業動向分析レポート:タイプ別、用途別、流通チャネル別、地域別展望と予測、2023年~2030年 |
出版日: 2023年10月31日
発行: KBV Research
ページ情報: 英文 337 Pages
納期: 即納可能
![]() |
ソフトジェルカプセル市場規模は、予測期間中にCAGR 5.8%で成長し、2030年には68億米ドルに達すると予測されます。2022年の市場規模は6億5,110万個で、成長率は7.0%(2019~2022年)です。
しかし、同市場における環境への懸念は、ゼラチンの重要な供給源である畜産業から生じています。畜産業は、土地の使用、水の消費、温室効果ガスの排出など、かなりのエコロジカル・フットプリントを持っています。また、ゼラチンの生産工程で溶剤やその他の化学薬品を使用するため、廃棄物が発生し、環境が汚染されることもあります。伝統的な石灰化に基づくゼラチン製造は労働集約的で、大量の廃水と土地汚染をもたらします。10%の廃棄物がゼラチン製造工程で排出されるが、この廃棄物は600℃の製造温度では加水分解されないです。今後数年間は、ソフトジェル製造廃棄物の処理による環境への悪影響が、おそらく市場拡大の妨げになると思われます。
タイプ別展望
タイプ別に見ると、市場はゼラチンと非ゼラチンに二分されます。ゼラチン・セグメントは2022年の市場で最も高い収益シェアを獲得しました。ソフトジェルカプセルのゼラチンシェルは、特定の薬物や栄養素のバイオアベイラビリティを高めることができます。消化管での分解から敏感な成分を保護し、活性化合物をより高い割合で体内に吸収させることができます。ゼラチンソフトジェルカプセルのサイズ、形状、色をカスタマイズすることで、ブランディングや製品の差別化を図ることができます。ゼラチンは動物のコラーゲンに由来し、生分解性であるため、カプセル製造には環境に優しい選択肢です。
流通チャネルの展望
流通チャネル別に見ると、市場は薬局・薬店、スーパーマーケット・ハイパーマーケット、オンラインプロバイダーに分けられます。薬局・薬店セグメントは2022年の市場で最大の収益シェアを獲得しました。薬局・薬店は医薬品を販売するための規制を受け、認可を受けています。つまり、これらの店舗で販売されているソフトジェルは高品質で安全基準を満たしています。このような店舗では、薬剤師やヘルスケア専門家が、特定の健康ニーズに合ったソフトジェルを選ぶためのアドバイスや指導を気軽に提供しています。彼らは、個人の健康状態、現在服用している薬、食事の必要条件などに基づいて、おすすめの商品を提案することができます。都市部や郊外に数多くの店舗があり、簡単にアクセスできます。この利便性により、個人は通常の買い物の一環としてソフトジェルを簡単に購入することができます。
用途別展望
用途別では、市場は医薬品、栄養補助食品、化粧品に区分されます。医薬品分野は2022年の市場成長率が顕著でした。ソフトジェルに含まれる液体または半液体は、特定の薬物のバイオアベイラビリティを高め、体内への吸収をより迅速かつ効果的にすることができます。これは、薬効が最大の関心事である医薬製剤において極めて重要です。医薬品ソフトジェルカプセルは、サイズや色をカスタマイズできるため、医薬品マーケティングにおいて重要なブランディングや製品の差別化が可能になります。医薬品成分をソフトジェルカプセルに封入すると、劣化から保護することで保存期間を延長でき、医薬品が長期間有効であることが保証されます。
地域別展望
地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。北米地域は、2022年に市場で最も高い収益シェアを獲得しました。ソフトジェルカプセルは、ビタミン、ミネラル、栄養補助食品、市販薬、処方薬など幅広い製品に使用されています。多様な用途が北米での需要の高さに寄与しています。北米の消費者は、敏感な成分や反応性の成分を含む製品を求めるようになっており、ソフトジェルカプセルは、これらの物質を劣化させる可能性のある湿気、空気、光からの保護に優れています。
The Global Softgel Capsules Market size is expected to reach $6.8 billion by 2030, rising at a market growth of 5.8% CAGR during the forecast period. In the year 2022, the market attained a volume of 651.1 million units, experiencing a growth of 7.0% (2019-2022).
Because of their vast populations, nations like China, India, and Japan are anticipated to have a significant increase in the market for softgel capsule raw materials. Therefore, the Asia Pacific region would account for more than 25% share of the market. The pharmaceutical sector in this region is also expected to expand because of growing health concerns, rising incomes, and improved government initiatives. When combined, these elements support the market's expansion in the Asia Pacific region. Numerous multinational pharmaceutical companies are expanding their operations or setting up new ones in the Asia Pacific region due to the region's low manufacturing costs and enormous growth potential. Some of the factors impacting the market are growing health and wellness awareness among consumers, rising preference for ingredients sourced naturally, and negative environmental impact of softgel manufacturing.
Consumers are increasingly proactive in seeking solutions to enhance their overall well-being, which aligns with the attributes and benefits of softgel capsules. The preference for softgels is largely attributed to their ease of consumption and improved bioavailability. As consumers become more informed about the importance of nutrition and supplementation, they seek products that are not only effective but also convenient to incorporate into their daily routines. Softgel capsules address this need by offering a dosage form that is easy to swallow, ensuring that individuals are more likely to adhere to their supplement regimens. Additionally, the demand for natural ingredients has been driven by consumers' growing concerns about their health. The belief among consumers that natural ingredients have a positive effect on health has led to a rise in the demand for products containing natural ingredients. Manufacturers are now more cautious about the ingredients they use in their products as a result of ingredient labeling. Frequent ingestion of artificial ingredients has been associated with foodborne illnesses, allergic reactions in sensitive individuals, and cancer. Because of this, there is a growing need for natural ingredients. Growing dietary supplement demand, the popularity of vegetarian and vegan diets, and the advancement of softgel capsule manufacturing technologies are some of the factors driving up demand for naturally sourced ingredients. These factors are expected to spur market expansion among consumers and the patient population.
However, the environmental concern in the market arises from the livestock industry, which is a significant source of gelatin. Livestock farming has a substantial ecological footprint, including land use, water consumption, and greenhouse gas emissions. The environment may be contaminated by the use of solvents and other chemicals during the gelatin production process, which can also produce waste products. Traditional liming-based gelatin production is labor-intensive and produces a large amount of wastewater and land pollution. 10% of waste is released during the gelatin production process; this waste is not hydrolyzed at the 600C production temperature. In the upcoming years, the detrimental effects of the disposal of softgel manufacturing waste on the environment are probably going to impede market expansion.
Type Outlook
Based on type, the market is bifurcated into gelatin and non-gelatin. The gelatin segment garnered the highest revenue share in the market in 2022. The gelatin shell of softgel capsules can enhance the bioavailability of certain drugs or nutrients. It helps to protect sensitive ingredients from degradation in the digestive tract, ensuring that the body absorbs a higher percentage of the active compound. Manufacturers can easily customize the size, shape, and color of gelatin softgel capsules to meet specific branding and product differentiation requirements, allowing for a unique and recognizable product appearance. Gelatin is derived from animal collagen and is considered biodegradable, making it an environmentally friendly choice for capsule production.
Distribution Channel Outlook
On the basis of distribution channel, the market is divided into pharmacies & drug stores, supermarkets & hypermarkets, and online providers. The pharmacies & drug stores segment acquired the largest revenue share in the market in 2022. Pharmacies and drug stores are regulated and licensed to sell pharmaceutical products. This means that the softgels available in these establishments are of high quality and meet safety standards. In such stores, pharmacists and healthcare professionals are readily available to provide advice and guidance on choosing the right softgels for specific health needs. They can offer recommendations based on an individual's health condition, existing medications, and dietary requirements. These are easily accessible, with numerous locations in urban and suburban areas. This convenience makes it simple for individuals to purchase softgels as part of their regular shopping routine.
Application Outlook
By application, the market is segmented into pharmaceuticals, nutraceutical & dietary supplements, and cosmetics. The pharmaceuticals segment witnessed a remarkable growth rate in the market in 2022. The liquid or semi-liquid content in softgels can enhance the bioavailability of certain drugs, allowing for faster and more effective absorption in the body. This can be vital in pharmaceutical formulations where drug efficacy is a primary concern. Pharmaceutical softgel capsules can be customized in size and color, allowing for branding and product differentiation, which can be crucial in pharmaceutical marketing. The encapsulation of pharmaceutical ingredients in softgel capsules can extend their shelf life by protecting them from degradation, ensuring that medications remain effective for extended periods.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region acquired the highest revenue share in the market in 2022. Softgel capsules are used in a broad spectrum of products, including vitamins, minerals, dietary supplements, over-the-counter medications, and prescription drugs. The diverse range of applications contributes to their high demand in North America. North American consumers are increasingly seeking products that contain sensitive or reactive ingredients, and softgel capsules offer excellent protection against moisture, air, and light, which can degrade these substances.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Gelita AG, Darling Ingredients, Inc., Nitta Gelatin, Inc., SAS Gelatines Weishardt, Lapi Gelatine S.p.a (Lapi Group), Captek Softgel International, Inc., Thermo Fisher Scientific, Inc., EuroCaps (DCC Plc), Lonza Group AG (Capsugel), and Procaps Group.
Market Segments covered in the Report:
By Type (Volume, Million Units, USD Billion, 2019-2030)
By Application (Volume, Million Units, USD Billion, 2019-2030)
By Distribution Channel (Volume, Million Units, USD Billion, 2019-2030)
By Geography (Volume, Million Units, USD Billion, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research